Cancer Research Meeting Calendar  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 39, 116-122, January 1, 1979]
© 1979 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, B. C.
Right arrow Articles by Busch, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, B. C.
Right arrow Articles by Busch, H.

Two-Dimensional Gel Electrophoresis of Cytosol Phosphoproteins of Novikoff Hepatoma and Regenerating Liver1

Benjamin C. Wu, William H. Spohn and Harris Busch

Department of Pharmacology, Baylor College of Medicine, Houston, Texas 77030

With two-dimensional isoelectric focusing sodium dodecyl sulfate gel electrophoresis, 32P-labeled cytosol proteins of Novikoff hepatoma and 18-hr regenerating rat liver were separated into 133 and 129 stained polypeptides, respectively. Approximately 103 polypeptides of both tissues had essentially identical migration characteristics. Seven dense spots (molecular weight in thousands/pl) 140/6.5, 72/6.7, 64/7.2, 35/7.7, 29/7.3, 28/7.1, and 27/7.2, that were found in the Novikoff hepatoma patterns were not present in the regenerating liver patterns. Six dense spots, 50/7.0, 50/7.4, 48/6.9, 43/8.2, 33/7.4, and 25/7.4, that were found in the regenerating liver were not found in the Novikoff hepatoma. Three spots, 95/5.7, 41/6.2, and 39/6.1, common to the Novikoff hepatoma and regenerating liver were not found in the normal liver. Autoradiograms of 32P-labeled proteins revealed 82 spots in Novikoff hepatoma and 88 spots in regenerating liver, 60 of which were common to both tissues; for Novikoff hepatoma, 5 g of cells were incubated with 300 mCi of carrier-free 32Pi, and for regenerating liver, 100 mCi carrier-free 32Pi were injected i.p. 15 hr after hepatectomy and 3 hr before sacrifice. Three 32P-labeled protein spots, 65/5.8, 25/5.5, and 25/6.0, were found only in the Novikoff hepatoma and 5 spots, 55/6.1, 45/7.0, 45/7.8, 42/5.9, and 24/5.5, were found in regenerating liver. These studies extend earlier reports of differences in spot patterns of Novikoff hepatoma and normal liver cytosol using the additional parameter of 32P-labeling as a marker for phosphoproteins.

1 This research was supported by the Cancer Center Grant CA-10893, P1, awarded by the National Cancer Institute, Department of Health, Education and Welfare; by the Bristol Fund, by the Pauline Sterne Wolff Memorial Foundation; and by a generous gift from Mrs. Jack Hutchins.

Received 7/ 5/78. Accepted 10/ 3/78.




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
S. P. Mirza and M. Olivier
Methods and approaches for the comprehensive characterization and quantification of cellular proteomes using mass spectrometry
Physiol Genomics, October 8, 2008; 33(1): 3 - 11.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1979 by the American Association for Cancer Research.